TITLE

High Prescription Drug Prices and the Influence of the Food and Drug Administration

AUTHOR(S)
Lawson, Gary W.
PUB. DATE
April 2004
SOURCE
Mayo Clinic Proceedings;Apr2004, Vol. 79 Issue 4, p569
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
Presents a letter to the editor to comment on the U.S. Food and Drug Administration's role in reducing high prescription drug prices.
ACCESSION #
12736836

 

Related Articles

  • High Prescription Drug Prices and the Influence of the Food and Drug Administration. Hubbard, William K. // Mayo Clinic Proceedings;Apr2004, Vol. 79 Issue 4, p569 

    Presents a letter to the editor to respond to the comment on the role of the U.S. Food and Drug Administration in the reduction of high prescription drug prices.

  • What Is the Role of the FDA Consumer Safety Officer?  // Applied Clinical Trials;Jan2010, Vol. 19 Issue 1, p14 

    A letter to the editor is presented in response to an article about the role of the U.S. Food and Drug Administration (FDA) Consumer Safety Officer in the previous issue.

  • FDA's drug and e-cigarette warnings counterproductive. Stier, Jeff; Beavers, Shyron M. // Hill;9/15/2009, Vol. 16 Issue 102, p28 

    Two letters to the editor are presented in response to articles in previous issues, such as one on the Food and Drug Administration's (FDA) warnings on drugs that treat Crohn's disease and colitis and e-cigarettes, a product used to quit smoking real cigarettes, in 2009.

  • No jake-legged reformers. Johnson, Greg // H&HN: Hospitals & Health Networks;Sep2007, Vol. 81 Issue 9, p8 

    A letter to the editor is presented in response to the article "Happy Tails, Jake Leg and the Food and Drug Administration" published online on August 7, 2007.

  • Letter to the Editor. Kelly, Tom L. // Medical Design Technology;Feb2005, Vol. 9 Issue 2, p9 

    Presents a letter to the editor about the policy at the U.S. Food and Drug Administration.

  • What Ails the FDA? Gorelick, Kenneth J. // New England Journal of Medicine;6/16/2005, Vol. 352 Issue 24, p2553 

    A letter to the editor is presented in response to an article on what ails the U.S. Food and Drug Administration (FDA) by researcher S. Okie in the March 17, 2005 issue.

  • What Ails the FDA? Marcus, Donald M. // New England Journal of Medicine;6/16/2005, Vol. 352 Issue 24, p2553 

    A letter to the editor is presented in response to an article on what ails the U.S. Food and Drug Administration (FDA) by researcher S. Okie in the March 17, 2005 issue.

  • What Ails the FDA? Cohen, Fredric J. // New England Journal of Medicine;6/16/2005, Vol. 352 Issue 24, p2553 

    A letter to the editor is presented in response to an article on what ails the U.S. Food and Drug Administration (FDA) by researcher S. Okie in the March 17, 2005 issue.

  • What Ails the FDA? Jenny-Avital, Elizabeth R. // New England Journal of Medicine;6/16/2005, Vol. 352 Issue 24, p2553 

    A letter to the editor is presented on the institutionalized influence of the U.S. pharmaceutical industry on the U.S. Food and Drug Administration (FDA).

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics